冠心病患者中奎尼丁反应性多形性室性心动过速
该回顾性研究纳入43例无急性心肌缺血证据的冠心病患者,多形性室速均由短联律间期(364±36 ms)室早触发,53%发生心律失常风暴且对常规抗心律失常药(含静脉胺碘酮)无效,但均对奎尼丁有反应。奎尼丁治疗者均存活出院,长期随访无复发。
要点
- 冠心病患者出现多形性室速,若联律间期短且无急性缺血,应考虑奎尼丁。
- 心律失常风暴对静脉胺碘酮等常规药物无效时,奎尼丁可能有效。
- 奎尼丁治疗者长期随访无室速复发,未用者复发率16%。
核心结论
- 冠心病患者反复多形性室速导致的心律失常风暴对其他抗心律失常药(包括静脉胺碘酮)无效时,对奎尼丁治疗有反应。
研究设计与样本
- 回顾性研究,纳入43例冠心病相关多形性室速患者,无急性心肌缺血证据。
主要发现
- 多形性室速事件均由短联律间期(364±36 ms)的期前收缩触发。
- 23例(53%)患者发生心律失常风暴(4-16次多形性室速恶化为心室颤动)。
- 心律失常风暴对常规抗心律失常治疗(包括静脉胺碘酮)始终无效,但对奎尼丁治疗均有反应。
- 心律失常风暴患者院内死亡率为17%;接受奎尼丁治疗的患者均存活至出院。
- 长期随访(5.6±6年,范围1个月至18年)中,未用奎尼丁出院的患者有3例(16%)复发多形性室速;奎尼丁治疗期间无复发性心律失常。
临床怎么用
- 冠心病患者出现无急性缺血证据的多形性室速,尤其由短联律间期室早触发时,应警惕心律失常风暴。
- 常规抗心律失常药物(包括静脉胺碘酮)无效时,可考虑使用奎尼丁治疗。
- 奎尼丁治疗可能减少长期复发,但需注意监测。
局限性
- 回顾性研究,样本量较小(43例),可能存在选择偏倚。
- 长期随访中失访情况未报告,且奎尼丁组与未用组非随机比较。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Polymorphic ventricular tachycardia (VT) without QT prolongation is well described in patients without structural heart disease (mainly idiopathic ventricular fibrillation and Brugada syndrome) and in patients with acute ST-elevation myocardial infarction. METHODS: Retrospective study of patients with polymorphic VT related to coronary artery disease, but without evidence of acute myocardial ischemia. RESULTS: The authors identified 43 patients in whom polymorphic VT developed within days of an otherwise uncomplicated myocardial infarction or coronary revascularization procedure. The polymorphic VT events were invariably triggered by extrasystoles with short (364±36 ms) coupling interval. Arrhythmic storms (4-16 events of polymorphic VT deteriorating to ventricular fibrillation) occurred in 23 (53%) patients. These arrhythmic storms were always refractory to conventional antiarrhythmic therapy, including intravenous amiodarone, but invariably responded to quinidine therapy. In-hospital mortality was 17% for patients with arrhythmic storm. Patients treated with quinidine invariably survived to hospital discharge. During long-term follow-up (of 5.6±6 years; range, 1 month to 18 years), 3 (16%) of patients discharged without quinidine developed recurrent polymorphic VT. There were no recurrent arrhythmias during quinidine therapy Conclusions: Arrhythmic storm with recurrent polymorphic VT in patients with coronary disease responds to quinidine therapy when other antiarrhythmic drugs (including intravenous amiodarone) fail.
引用
- Viskin S, Chorin E, Viskin D, et al. Quinidine-Responsive Polymorphic Ventricular Tachycardia in Patients With Coronary Heart Disease. Circulation. 2019. PMID: 30696267. doi:10.1161/CIRCULATIONAHA.118.038036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。